Cargando…
A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients
This study aimed to validate the long-term prognostic value of a new clinical-genomic model, Distant Genetic Model-Clinical Variable Model 6 (DGM-CM6), developed in Asia as a prognostic panel for all subtypes of breast cancer. We included 752 operable stage I–III breast cancer patients representing...
Autores principales: | Huang, Tzu-Ting, Lei, Lei, Chen, Ching-Hsuan Andre, Lu, Tzu-Pin, Jen, Chung-Wen, Cheng, Skye Hung-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078190/ https://www.ncbi.nlm.nih.gov/pubmed/32184406 http://dx.doi.org/10.1038/s41598-020-61535-9 |
Ejemplares similares
-
Gene expression profiling in prognosis of distant recurrence in HR-positive and HER2-negative breast cancer patients
por: Huang, Tzu-Ting, et al.
Publicado: (2018) -
Development of a prediction model for breast cancer based on the national cancer registry in Taiwan
por: Huang, Ching-Chieh, et al.
Publicado: (2019) -
DGM-CM6: A New Model to Predict Distant Recurrence Risk in Operable Endocrine-Responsive Breast Cancer
por: Lei, Lei, et al.
Publicado: (2020) -
MEGF11 is related to tumour recurrence in triple negative breast cancer via chemokine upregulation
por: Chiu, Jen-Hwey, et al.
Publicado: (2020) -
The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis
por: Pedersen, Rikke Nørgaard, et al.
Publicado: (2021)